[Results of combined administration of anabolis steroids in patients with multiple sclerosis].
D000284:Administration, Oral; D000324:Adrenocorticotropic Hormone / Q000627:therapeutic use; D000328:Adult; D045930:Anabolic Agents / Q000627:therapeutic use*; D001835:Body Weight; D004357:Drug Synergism; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D007275:Injections, Intravenous; D008297:Male; D008696:Methandrostenolone / Q000628:therapy; D008875:Middle Aged; D009103:Multiple Sclerosis / Q000188:drug therapy*; D009277:Nandrolone / Q000627:therapeutic use
D045930:Anabolic Agents; D007166:Immunosuppressive Agents; D009277:Nandrolone; D000324:Adrenocorticotropic Hormone; D008696:Methandrostenolone
Wyniki skojarzonego stosowania sterydów anabolicznych u chorych na stwardnienie rozsiane.